Village Farms CEO Michael DeGiglio buys $24,960 in shares

Village Farms International, Inc. (NASDAQ:VFF), a $135 million market cap company, saw its Chief Executive Officer Michael DeGiglio recently increase his stake by purchasing 20,000 common shares. The timing appears strategic, as InvestingPro data shows the stock has gained over 50% in the past six months. The transactions took place on May 23, 2025, at a weighted average price of $1.248 per share, resulting in a total investment of $24,960. Following these purchases, DeGiglio’s direct ownership in Village Farms stands at 9,633,127 shares. The shares were acquired in multiple open market transactions, with prices ranging from $1.245 to $1.25 per share. According to InvestingPro analysis, analysts maintain a Strong Buy consensus with price targets ranging from $2.50 to $3.00, suggesting potential upside. The stock currently trades with high volatility, with a beta of 2.17. Get access to 13 additional exclusive ProTips and comprehensive analysis in the Pro Research Report.

In other recent news, Village Farms International reported its fourth-quarter 2024 earnings, revealing an 11% year-over-year revenue increase to $83 million, although it missed earnings per share (EPS) expectations, posting a net loss of $0.08 per share against a forecasted loss of $0.02. The company has also entered a strategic partnership with Vanguard Food, contributing its produce business assets and securing a $40 million payment and 37.9% equity ownership in Vanguard Food LP. Village Farms has successfully refinanced its Canadian Cannabis Term Loans, consolidating three loans into a single credit facility with a lower interest rate and extended maturity date, which is expected to enhance financial flexibility. Additionally, the company has renegotiated its credit agreement with Farm Credit Canada, introducing improved financial covenants aimed at supporting its growth in the cannabis sector. Village Farms has been granted a 180-day extension by Nasdaq to meet the minimum bid price requirement, giving it until October 2025 to comply. The company is also focusing on international expansion, with plans to triple its international medicinal export sales in 2025. These developments reflect Village Farms’ ongoing efforts to strengthen its financial position and expand its market presence.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.